Fibrinolytic proteins in apoptotic human umbilical vein endothelial cells

Thrombosis Research

Volumn 91, Issue 5, 1998, Pages 209-219

  Zoellner, Hans ^a,b   Höfler, Manfred ^a   Beckmann, Rennate ^a   Bielek, Edith ^a   Vanyek, Erica ^a   Kumabashiri, Ichiro ^a   Binder, Bernd ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Apoptosis; Endothelium; Fibrinolysis; Microthrombosis

Indexed keywords

CYCLOHEXIMIDE; CYTOKINE; DNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; FIBRINOLYSIS; HUMAN; HUMAN CELL; INFLAMMATION; MICROTHROMBUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

APOPTOSIS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FIBRINOLYSIS; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032168499     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00087-5     Document Type: Article

References (38)

1. Gerschenson L.E., Rotello R.J. Apoptosis. A different type of cell death FASEB J. 6:1992;2450-2455.
2. Raff M.C., Barres B.A., Burne J.F., Coles H.S., Ishizaki Y., Jacobson M.D. Programmed cell death and the control of cell survival. Lessons from the nervous system Science. 262:1993;695-700.
3. Vaux D.L., Haecker G., Strasser A. An evolutionary perspective on apoptosis. Cell. 76:1994;777-779.
4. Payne C.M., Bjore C.G. Jr., Schultz D.A. Change in the frequency of apoptosis after low- and high dose X irradiation of human lymphocytes. J Leukoc Biol. 52:1992;433-440.
5. Loskutoff D.J., Curriden S.A. The fibrinolytic system of the vessel wall and its role in the control of thrombosis. Ann NY Acad Sci. 598:1990;238-247.
6. Zoellner H., Wojta J., Gallicchio M., McGrath K., Hamilton J.A. Cytokine regulation of the synthesis of plasminogen activator inhibitor-2 by human vascular endothelial cells. Thromb Haemost. 69:1993;135-145.
7. Wojta J., Gallicchio M., Zoellner H., Filonzi E.L., Hamilton J.A., McGrath K. Interleukin-4 stimulates expression of urokinase type plasminogen activator in cultured human foreskin microvascular endothelial cells. Blood. 81:1993;3285-3292.
8. Wojta J., Holzer M., Hufnagl P., Christ G., Hoover R.L., Binder B.R. Hyperthermia stimulates plasminogen activator inhibitor type 1 (PAI-1) expression in human umbilical vein endothelial cells (HUVEC) in vitro. Am J Pathol. 139:1991;911-919.
9. Kooistra T., Schrauwen Y., Arts J., Emeis J.J. Regulation of endothelial cell t-PA synthesis and release. J Hematol. 59:1994;233-255.
10. Barnathan E.S., Kuo A., Kariko K., Rosenfeld I., Murray S.C., Behrendt N., Ronne E., Weiner D., Henkin J., Cines D.B. Interaction of single chain urokinase-type plasminogen activator with human endothelial cells. Blood. 76:1990;1795-1806.
11. Barnathan E.S., Kuo A., Rosenfeld I., Kariko K., Leski M., Robbiati F., Nolli M.L., Henkin J., Cines D.B. Interaction of single chain urokinase-type plasminogen activator with human endothelial cells. J Biol Chem. 265:1990;2865-2872.
12. Hoyer-Hasen G., Behrendt N., Ploug M., Dano K., Preissner K.T. The intact urokinase receptor is required for efficient vitronectin binding. Receptor cleavage prevents ligand interaction FEBS Lett. 420:1997;79-85.
13. Kanse S.M., Benzakour O., Kanthou C., Kost C., Lijnen H.R., Preissner K.T. Induction of vascular SMC proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders. Arteriosc Thromb Vasc Biol. 17:1997;2848-2854.
14. Fazioli F., Resnati M., Sidenius N., Higashimoto Y., Appella E., Blasi F. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. EMBO J. 16:1977;7279-7286.
15. Kumar S., Balioni C. Protection from tumour necrosis factor mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J Biol Chem. 266:1991;20960-20964.
16. Dickinson J.L., Bates E.J., Ferrante A., Antalis T.M. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. J Biol Chem. 270:1995;27894-27904.
17. Pepper M.S., Vassalli J.D., Montesano R., Orci L. Urokinase type plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol. 111:1987;2535-2541.
18. Pepper M.S., Sappino A.P., Stocklin R., Montesano R., Orci L., Vassalli J.D. Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol. 122:1993;673-684.
19. Meeson A., Palmer M., Calfon M., Lang R. A relationship between apoptosis and flow during programmed capillary regression is revealed by vital analysis. Development. 122:1996;3929-3938.
20. Walker N.I., Gobe G.C. Cell death and cell proliferation during atrophy of the rat parotid gland induced by duct obstruction. J Pathol. 153:1987;333-344.
21. Walker N.I., Bennett R.E., Kerr J.F. Cell death by apoptosis during involution of the lactating breast in mice and rats. Am J Anat. 185:1989;19-32.
22. Polunovsky V.A., Chen B., Henke C., Snover D., Wendt C., Ingbar D.H., Bitterman P.B. Role of mesenchymal cell death in lung remodelling after injury. J Clin Invest. 92:1993;388-397.
23. Gobe G., Browning J., Howard T., Hogg N., Winterford C., Cross R. Apoptosis occurs in endothelial cells during hypertension induced microvascular rarefaction. J Struct Biol. 118:1997;63-72.
24. Araki S., Shimada Y., Kaji K., Hayashi H. Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun. 168:1990;1194-1200.
25. Araki S., Simada Y., Kaji K., Hayashi H. Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum depleted endothelial cells. Biochem Biophys Res Commun. 172:1990;1081-1085.
26. Meredith J.E.J., Fazeli B., Schwartz M.A. The extracellular matrix as a cell survival factor. Mol Biol Cell. 4:1993;953-961.
27. Zoellner H., Höfler M., Beckmann R., Hufnagl P., Vanyek E., Bielek E., Wojta J., Fabry A., Lockie S., Binder B.R. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci. 109:1996;2571-2580.
28. Zoellner H., Bielek E., Vanyek E., Fabry A., Wojta J., Höfler M., Binder B.R. Canalicular fragmentation of apoptotic human endothelial cells. Endothelium. 4:1996;177-188.
29. Greeno E.W., Bach R.R., Moldow C.F. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest. 75:1996;281-289.
30. Maciag T, Hoover GA, Stemerman MB, Weinstein R. Factors which stimulate the growth of human umbilical vein endothelial cells in vitro. In: Jaffe EA, editor. Biology of Endothelial Cells. Dordrecht, The Netherlands: 1984. p. 87-96.
31. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 52:1973;2745-2756.
32. Smith C.A., Williams G.T., Kingston R., Jenkinson E.J., Owen J.J. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature. 337:1989;181-184.
33. Wojta J., Binder B.R., Humber K., Hoover R.L. Evaluation of fibrinolytic capacity in plasma during thrombolytic therapy with single (scu-PA) or two-chain urokinase type plasminogen activator (tcu-PA) by a combined assay system for urokinase type plasminogen activator antigen and function. Thromb Haemost. 61:1989;289-293.
34. Wojta J., Turcu L., Wagner O.F., Korninger C., Binder B.R. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies. J Lab Clin Med. 109:1987;665-671.
35. Dimmeler S., Haendeler J., Rippmann V., Nehls M., Zeiher A.M. Shear stress inhibits apoptosis in human endothelial cells. FEBS Lett. 399:1996;71-74.
36. Grondahl-Hansen J., Kirkeby L.T., Ralfiaer E., Kristensen P., Lund L.R., Dano K. Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix. Am J Pathol. 135:1989;631-636.
37. Robaye B., Mosselmans R., Fieps W., Dumont J.E., Geland P. Tumour necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol. 138:1991;447-453.
38. Tsukada T., Eguchi K., Migita K., Kawabe Y., Kawakami A., Matsouka N., Takashima H., Mizokami A., Nagataki S. Transforming growth factor beta 1 induces apoptotic cell death in cultured human umbilical vein endothelial cells with down regulated expression of bcl-2. Biochem Biophys Res Commun. 201:1995;1076-1082.